
Hematólogo de pura cepa. Hospital Clínic de Barcelona Inside @hospitalclinic @hematoclinicbcn #Thrombosis #Anticoagulation #MPN #MPNsm #GEMFIN
Barcelona, España
Joined August 2018
- Tweets120
- Following89
- Followers56
- Likes127
In #CALR-mutated #ET, high allele burden ≥ 35% was associated with a lower likelihood of achieving complete hematological response and with an increased risk of arterial thrombosis, progression to #myelofibrosis and death
#MPN #GEMFIN @Hemasphere_EHA
doi.org/10.1002/hem3.70325
Eduardo Arellano-Rodrigo, MD retweeted
Targeting BCMA: a double-edged sword for infection risk ashpublications.org/blood/ar…
Eduardo Arellano-Rodrigo, MD retweeted
'Optical genome mapping in myelofibrosis: enhancing prognostic accuracy through high-resolution genomic profiling' read in Blood Advances: ow.ly/cMhX50Y4wZK
Eduardo Arellano-Rodrigo, MD retweeted
Circulating Cues Prime Endothelium in MPN-Related SVT. You can read the new article on our recently published manuscript here: bloodcancerstoday.com/post/c…
Proteomic profiling links complement activation to splanchnic vein thrombosis in JAK2V617F myeloproliferative neoplasms
@blanca_demoner @diaz_ricart #MPNsm @hematoclinicbcn @idibaps @UniBarcelona @CarrerasIJC
doi.org/10.1016/j.tranon.202…
Eduardo Arellano-Rodrigo, MD retweeted
📢 ¡Ya disponible la edición 2025 del Manual de Recomendaciones GEMFIN en Neoplasias Mieloproliferativas Crónicas Filadelfia Negativas!
Una herramienta clave para la práctica clínica.
📘 Descárgalo aquí 👉 manual-gemfin2025.gemfin.org
#GEMFIN #MPN #Hematología @sehh_es @HematoRYC
Eduardo Arellano-Rodrigo, MD retweeted
🔴 Comienza nuestra IX Reunión Anual del grupo GEMFIN. Excelente programa educacional y revisión de proyectos en marcha. ¡Más de 160 asistentes! Un éxito de participación. @sehh_es #GEMFIN #Hematología #MPN
Eduardo Arellano-Rodrigo, MD retweeted
Outstanding talk by Dr. William Vainchenker at the GEMFIN Annual Meeting:
“Twenty years since the discovery of JAK2 V617F. Molecular advances in MPNs since then.”
A privilege to learn from one of the pioneers in the field. #MPNs #JAK2 #Hematology #GEMFIN2025
Eduardo Arellano-Rodrigo, MD retweeted
¡Recién salidas del horno! 📘 Presentamos en nuestra reunión anual las nuevas guías GEMFIN.
Esperamos que sean una herramienta de gran utilidad para todos los compañeros implicados en el manejo de las NMP. #GEMFIN2025 #NMP #Hematología @sehh_es
Eduardo Arellano-Rodrigo, MD retweeted
It's out!! I am thrill to share with you our new paper in @BloodJournal where we show that JAK2 46/1 haplotype regulates PD-L1 expression. This opens the door to new research lines and, who knows, future treatments for our MPN patients.
authors.elsevier.com/sd/arti…
Eduardo Arellano-Rodrigo, MD retweeted
Our latest study from the GEMFIN group has just been published in Blood Cancer Journal!
We report real-world data on the efficacy and safety of momelotinib in patients with myelofibrosis: nature.com/articles/s41408-0…
@sehh_es
Eduardo Arellano-Rodrigo, MD retweeted
📢Nos complace compartir que nuestros compañeros, @GonzaloHEM y JC Hernández-Boluda, han publicado dos artículos originales en la prestigiosa revista Blood.Gran logro de la Hematología española y GEMFIN. Enhorabuena a los autores! 👏 @sehh_es @mpnspain_
Eduardo Arellano-Rodrigo, MD retweeted
Very happy to be part of this international collaboration 🇨🇦🇫🇷🇪🇸🇳🇿🇩🇪 defining the VITT-like Monoclonal Gammopathy of Thrombotic Significance @hospitalclinic nejm.org/doi/full/10.1056/NE…
Eduardo Arellano-Rodrigo, MD retweeted
📢 La EPACAR-T evalúa mediante escalas validadas e identifica a los candidatos que pueden beneficiarse de soporte psicológico y social para mejorar su salud. elsevier.es/es-revista-enfer… @Crismar82 @enfClinica @hematoclinicbcn @hospitalclinic #Payora #CRamos #Ggarcia #ADomènech
Circulating factors in JAK2V617F-mutated #MPN with splanchnic vein thrombosis induce endothelial proinflammatory and prothrombotic phenotypes, which are modulated by therapy
@blanca_demoner @martagarrote @BloodyMeri_Xell @jcgarciapagan @diaz_ricart
@hematoclinicbcn
High-risk patients achieving complete hematological response to first-line hydroxyurea showed a reduced risk of arterial thrombosis, a lower rate of progression to myelofibrosis and better survival: Data from Spanish Registry of ET
#MPN @LeukemiaJnl
nature.com/articles/s41375-0…
Impact of Non-Driver Mutations on Thrombosis and Predictive Value of Arterial Thrombosis Score (ARTS) and Venous Thrombosis Score (VETS) in #myelofibrosis: Insights from the #GEMFIN Registry
#MPN #MPNsm @hematoclinicbcn @LeukemiaJnl
doi.org/10.1038/s41375-024-0…




















